Tennessee Oncology and Flatiron Health Partner to Advance the Development of Value-Based Care Products and Services

As part of this partnership, Tennessee Oncology will transition to Flatiron Health’s OncoCloud suite of products including OncoEMR and OncoAnalytics

NEW YORK, NY, July 14, 2016

Tennessee Oncology and Flatiron Health today announced a collaboration that will focus on the development of value-based care solutions for cancer care providers to leverage in today’s rapidly evolving reimbursement landscape.

In addition, Tennessee Oncology, one of the largest private, community-based practices in the nation, will utilize Flatiron Health’s OncoEMR®, OncoAnalytics® and new value-based care solution to help ensure successful participation in the Centers for Medicare and Medicaid Services Oncology Care Model (OCM) program. These offerings are part of Flatiron Health’s new OncoCloudTM suite, the industry’s most comprehensive cloud-based software offering for community oncology practices.

“Like us, Flatiron Health is dedicated to helping define the future of cancer care,” said Jeff Patton, MD, CEO of Tennessee Oncology. “We chose them because we needed a long-term partner in innovation. By utilizing their oncology software suite as a foundation, we can combine our expertise and insights to further advance the delivery of high quality care at lower costs to patients.”

Tennessee Oncology and Flatiron Health will focus on leveraging Flatiron’s software and services to enable the development of new value-based care solutions, with a shared commitment to investing heavily in the future of oncology payment reform and technology to improve quality and cost. Tennessee Oncology will also utilize OncoAnalytics to identify further opportunities to enhance the quality and value of care they provide to their patients.

“Oncology care delivery is changing at an incredibly fast pace, especially with new value-based care programs like the Oncology Care Model,” said Robin Shah, Head of Strategic Initiatives, Flatiron Health. “We are very excited about the collaboration opportunities this partnership allows for in order to empower providers across the nation to prepare for the future of value-based care.”

About Flatiron

Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. Through clinical and data science, we translate patient experiences into real-world evidence to improve treatment, inform policy, and advance research. Cancer is smart. Together, we can be smarter. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth